DR
CELG

Davis Rea’s Celgene Corp CELG Stock Holding History

Davis Rea’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-42,300
Closed -$4.41M – 51
2017
Q4 		$4.41M Sell
42,300
-36,479
-46% -$4.12M 2.44% 16
2017
Q3 		$11.5M Buy
78,779
+130
+0.2% +$17.7K 6.76% 2
2017
Q2 		$10.2M Buy
78,649
+50
+0.1% +$6.13K 6.47% 2
2017
Q1 		$9.78M Buy
78,599
+672
+0.9% +$80.4K 6.57% 2
2016
Q4 		$9.02M Buy
77,927
+11,803
+18% +$1.31M 6.42% 3
2016
Q3 		$6.91M Buy
66,124
+2,007
+3% +$217K 5.15% 7
2016
Q2 		$6.32M Buy
64,117
+42,572
+198% +$4.4M 4.49% 11
2016
Q1 		$2.16M Sell
21,545
-90
-0.4% -$9.27K 1.57% 20
2015
Q4 		$2.59M Buy
21,635
+2,935
+16% +$340K 1.61% 22
2015
Q3 		$2.02M Buy
18,700
+744
+4% +$92.3K 1.23% 24
2015
Q2 		$2.08M Buy
17,956
+446
+3% +$51K 1.28% 22
2015
Q1 		$2.02M Buy
+17,510
New +$2.09M 1.31% 25

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Davis Rea's CELG Position: Q1 2018 in Review

Davis Rea sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 42,300 shares — an estimated $4.41M sold.

Davis Rea first reported a position in CELG in Q1 2015 and held it in 12 quarters. The position peaked at $11.5M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Davis Rea reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Davis Rea sold 42,300 Celgene Corp shares in Q1 2018, an estimated $4.41M.
  • Davis Rea first reported a position in Celgene Corp in Q1 2015 and held it in 12 quarters.
  • Davis Rea's Celgene Corp position peaked at $11.5M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Davis Rea's 13F filing for Q1 2018, filed 6 Apr 2018.